Previous 10 | Next 10 |
Artivion to Participate in the UBS 2022 Global Healthcare Conference PR Newswire ATLANTA , May 16, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT) , a leading cardiac and vascular surgery company focused on aortic disease, today announced that it wil...
Artivion, Inc. (AORT) Q1 2022 Earnings Conference Call May 5, 2022 16:30 ET Company Participants Brian Johnston - Investor Relations Pat Mackin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Suraj Kalia - Oppenheimer Presentation...
Artivion press release (NYSE:AORT): Q1 Non-GAAP EPS of $0.03. Revenue of $77.2M (+8.6% Y/Y). For FY22, the company continues to expect constant currency revenue growth of between 9.0% and 11.0%, compared to FY21. For further details see: Artivion Non-GAAP EPS of $0.03, revenue of $77.2M...
Artivion Reports First Quarter 2022 Financial Results PR Newswire Achieved revenue of $77.2 million in the first quarter 2022 versus $71.1 million in the first quarter of 2021, an increase of 8.6% on a GAAP basis and 11.2% on a non-GAAP constant currency basi...
ArtivionAnnounces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results PR Newswire ATLANTA , April 21, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, ann...
Artivion to Participate in the 21st Annual Needham Virtual Healthcare Conference PR Newswire ATLANTA , March 31, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that i...
Artivion Publishes Inaugural Corporate Responsibility Report PR Newswire ATLANTA , March 14, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today published its inaugural Corporat...
Artivion to Host Investor & Analyst Day on March 23, 2022 Artivion to Host Investor & Analyst Day on March 23, 2022 PR Newswire ATLANTA , March 9, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused...
Artivion to Participate in the Oppenheimer 32nd Annual Healthcare Conference PR Newswire ATLANTA , March 3, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it wil...
Artivion, Inc. (AORT) Q4 2021 Earnings Conference Call February 17, 2022, 04:30 PM ET Company Participants Brian Johnston - VP, IR, Gilmartin Group LLC J. Patrick Mackin - Chairman, President and CEO D. Ashley Lee - EVP, COO, and CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thal...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 12:00:05 ET Frank Takkinen from Loop Capital Markets issued a price target of $30.00 for AORT on 2024-07-02 08:49:00. The adjusted price target was set to $30.00. At the time of the announcement, AORT was trading at $26.015. The overall price target consensus ...
Artivion Amends Agreements with Endospan PR Newswire Provides Endospan with $25 million of Additional Debt Funding to Obtain FDA Approval for NEXUS Upfront Payment Associated with Purchase Option Reduced to $135 million , inclusive of loan off-set, and $100 m...